US stocks · open long, week 22
Biogen gains 2.7% off its 20-day average as money flow turns positive again
Our view last week
A new 90-day high in the 230 area, then a retreat: Biogen closed the week down 3.4%, at the low of its range, leaving the break unconfirmed. Weekly money flow turned negative after 16 positive weeks, while the MACD holds above its Signal line with a thinner margin. For Biogen stock it is a step back from the 5.6% gain of 7 days earlier: among US stocks, this swing trading setup is still up 13.7% since entry.
This week's summary
Last week's step back lasted a single week: Biogen recovers 2.7%, reclaims its 20-day moving average in the 222 area, and weekly money flow is straight back above zero. Biogen stock still stalls just below its 90-week high in the 230 area, a zone tested several times in recent weeks. For price action it is an open test: among US stocks, this swing trading setup is now up 16.7% since entry.
IQS Phase
58
ordinary
Signal Strength
47
medium · weak
Sizing
REDUCED
Ranking
#66 / 92
US stocks in progress
Trade P&L %
+16.68%
from signal to date, no stop loss
Biogen (BIIB) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 66th among the 92 Longs already running for US stocks in our ranking, with a signal strength of 47 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +2.79% · monthly +2.54%
BIIB belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content